Now Live: Cboe Europe real-time data for all major European stocks.
opens in 2d 11h 3m
Market closed

Pre-market opens in 2 days 5 hours 33 minutes
Main market opens in 2 days 11 hours 3 minutes

22:26
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).
89.33000 EUR
0.76
0.86%
Last update Apr 2, 3:08 PM CEST
Market closed
Day range
88.040001
89.33000
Previous close
88.57000
Open
88.040001
Access this stock data via API
Subscribe
Abbott Laboratories
89.33
0.76
0.86%

Overview

Access /time_series data via our API — starting from the Basic plan and above.

Description

Abbott Laboratories is a diversified global healthcare company that discovers, develops, manufactures, and sells a broad portfolio of health care products worldwide. It operates across four key segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, addressing needs from chronic disease management to acute diagnostics. The company offers generic pharmaceuticals treating conditions such as pancreatic exocrine insufficiency, irritable bowel syndrome, dyslipidemia, hypertension, hypothyroidism, pain, fever, inflammation, and migraine, alongside anti-infectives, influenza vaccines, and gastrointestinal regulators. Notable products include cardiovascular devices like pacemakers and stents, diabetes management tools such as continuous glucose monitors, pediatric and adult nutritional formulas, and advanced diagnostic equipment like immunoassays and point-of-care testing kits. With approximately 114,000 employees and a history dating back to 1888, Abbott Laboratories generates the majority of its sales outside the United States, playing a pivotal role in advancing medical innovation, improving patient outcomes, and supporting global health initiatives through its extensive reach in consumer, institutional, and professional markets.

About

CEO
Mr. Robert B. Ford
Employees
115000
Address
100 Abbott Park Road
Abbott Park
Lake County, 60064-6400, IL
United States
Phone
224 667 6100
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Medical Devices
Country
Germany
MIC code
XFRA
Access /profile data via our API — starting from the Grow plan (individual) and the Venture plan (business) and above.

Latest press releases

Nov 10, 2025
Abacus Global Management (NASDAQ: ABL) Brings Longevity Investment Strategy to Middle East Investors Following Russell Index Inclusion

DUBAI, UAE, Nov. 10, 2025 /PRNewswire/ -- Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL), a leader in alternative asset management, announced that it has been added to the Russell 2000® and Russell 3000® Indexes. This milestone reflects the firm's strong growth and the increasing institutional recognition of secondary life insurance assets as a mainstream, diversifying component of modern portfolio construction.

As investors navigate a world of moderating base rates and tighter credit spreads, the appeal of uncorrelated, actuarially driven strategies has strengthened. Secondary life insurance assets, characterized by predictable, mortality-linked cash flows, are emerging as a natural complement to income-generating alternatives such as private credit. They offer yield stability, diversification, and downside protection amid changing market conditions.

Jay Jackson, Chairman and CEO of Abacus, commented, "Inclusion in these Russell indices marks an important milestone in our company's journey, enhancing our visibility among the broader investment community and validating our team's ability to drive value for shareholders."

Building on this momentum, Abacus will lead a Middle East roadshow in November to meet with institutional investors and family offices. The initiative highlights Abacus's commitment to broadening global access to data-driven, uncorrelated investment opportunities at a time when resilient alternative strategies are increasingly in demand.

According to Moody's, the global private credit market will reach $3 trillion in AUM by 2028 (Moody's, 2025). This growth is being driven by bank retrenchment and investors' ongoing search for yield. As competition intensifies and spreads compress, institutional allocators are increasingly turning toward uncorrelated asset classes such as secondary life insurance portfolios to enhance portfolio efficiency and risk-adjusted returns.

Abacus combines proprietary mortality data, in-house underwriting, and active portfolio management to effectively manage longevity risk and deliver consistent performance. The firm continues to see growing institutional inflows from investors seeking uncorrelated returns that complement traditional fixed income and private credit allocations.

About Abacus

Abacus Global Management (NASDAQ: ABL) is a leading financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. With a focus on longevity-based assets and personalized financial planning, Abacus leverages proprietary data analytics and decades of industry expertise to deliver innovative solutions that optimize financial outcomes for individuals and institutions worldwide.

For more information, please visit abacusgm.com.

To schedule a meeting with Abacus during their Middle East roadshow, please contact the details below.

Nitin Mathew

Vice President – Investor Relations

nmathew@ib-cap.com | info@cmclux.com

+971 585 146 881

Cision View original content:https://www.prnewswire.co.uk/news-releases/abacus-global-management-nasdaq-abl-brings-longevity-investment-strategy-to-middle-east-investors-following-russell-index-inclusion-302608511.html

Sep 11, 2025
Abacus Global Management - Secondary Life Insurance - Building Momentum and A Rising Alternative in Asia

SINGAPORE, Sept. 11, 2025 /PRNewswire/ -- In a year marked by persistent volatility across equities, credit, and real estate, Asian allocators are increasingly looking to uncorrelated sources of return. Secondary life insurance – or life settlements – is gaining further recognition in the region as a reliable, actuarially driven strategy. By acquiring existing U.S. life insurance policies at a discount and maintaining premiums until maturity, managers like Abacus provide stable returns  tied to longevity outcomes rather than market cycles.

Globally, life settlements already represent a multi-trillion-dollar opportunity, with over USD 200 billion worth of policies lapsing each year in the U.S. often due to limited awareness of better alternatives among senior policyholders. While well-established in the U.S. and Europe, this asset class remains nascent in Asia. However, as family offices and institutional allocators in the region build more sophisticated portfolios, many are turning to this uncorrelated strategy to diversify risk and benefit from predictable cash flows secured by highly rated US life insurance companies.

Growing Presence in AsiaSingapore, Hong Kong SAR, and Japan

Abacus has established a strong investor base in Japan and Singapore. Looking ahead, the firm sees significant opportunities to expand further in these two markets as well as Hong Kong SAR, where demand for alternative credit and longevity-linked assets is accelerating.

As part of this expansion, Abacus will host an investor roadshow in Singapore and Japan this October and November, bringing senior management to meet with existing and new investors. This underscores Abacus' vision to become the partner of choice for Asian allocators seeking stability in uncertain markets.

With nearly $3 billion in assets under management, Abacus Global Management (NASDAQ: ABL) is the only publicly traded global alternative asset manager focused on lifespan-based financial products. Regulated by the SEC in the U.S. and the CSSF in Luxembourg, the firm complies with the strictest transparency requirements in its industry.

ARF IV – Available Vintage

The Absolute Return Fund IV (ARF IV) continues to build on a track record of disciplined actuarial modelling, rigorous risk management, and consistent distributions. The fund is structured to deliver double digit net returns with quarterly distributions, offering investors bond-like regularity alongside the growth potential of a niche, uncorrelated asset class.

The fund performance has maintained a consistent record of strong performance since its inception, accounting at cost and realized gains only.

Looking Ahead

With secondary life insurance gaining traction in Asia, Abacus is well positioned to lead this next phase of growth. Combining a global track record with a growing presence in Singapore, Hong Kong SAR, and Japan, the firm offers allocators a strategy built on stability, transparency, and performance.

Contacts:

Stephane Haot
Senior Partner – Investor Relations
https://lu.linkedin.com/in/stephanehaot
Mobile: +352 621 287 861 | +951 50 287 1245

Background about Carlisle Management Company part of Abacus Global Management

Carlisle Management Company S.C.A was acquired by Abacus Global Management (NASDAQ: ABL) back in December 2024. Established in 2008, Carlisle is a leading, highly diversified global investment management firm. Carlisle is licensed as an Alternative Investment Fund Manager under the supervision of the CSSF in Luxembourg, the second largest domicile for investment funds in the world.

The Carlisle team is at the forefront of the life settlement industry, establishing a new standard for transparent transactions, maintaining integrity, and creating exceptional opportunities for secondary life insurance investors and policyholders. Carlisle's state-of-the-art facilities and statistical modelling systems incorporate knowledge gained from over 60 years of combined investment experience within the alternative assets sector.

CisionView original content:https://www.prnewswire.com/apac/news-releases/abacus-global-management--secondary-life-insurance--building-momentum-and-a-rising-alternative-in-asia-302548768.html

SOURCE Abacus Global Management

Access /press_releases data via our API — starting from the Basic plan and above.
Market closed

Exchange is currently closed (non-working day)
Main market opens in 3 days 3 hours 33 minutes

04:26
00:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CEST, UTC+02:00).